Since the Zeeh Station opened in 2003, its scientists have completed more than 550 projects, of which more than 60 were collaborations with on-campus researchers.
Research
Putting the Patient Back into the Health Care Equation
Assistant Professor Olayinka Shiyanbola’s research on medication adherence takes patient-centered approach.
Improved Capture of Cancer Cells in Blood Could Help Track Disease
New research by Professor Seungpyo Hong and his collaborators demonstrates improved methods for capturing circulating tumor cells on clinical samples for the first time.
Cancer Patients Who Tell Their Life Story Find More Peace, Less Depression
Associate scientist Meg Wise held phone interviews with cancer patients to produce a manuscript for patients to share with their friends and family.
Embedding Research Experience To Support Pharm-Tox Students’ Career Goals
School’s undergrad Pharmacology-Toxicology program offers broad research opportunities from exploring fish endocrinology to fighting antibiotic resistance.
Beth Martin Named an APhA-APRS Fellow
Beth Martin has been a contributing member of the APhA since 1987, while she was still a student at the School of Pharmacy.
Improving Cancer Diagnosis and Treatment
Two professors at the UW–Madison School of Pharmacy’s Pharmaceutical Sciences Division are up for the challenge of being both entrepreneurs and academic researchers, and they’re both targeting cancer.
Leveraging Technology to Keep Patients Safe
CancelRx is the only tool that automatically alerts the pharmacy when a doctor discontinues a drug for a patient. Associate Professor Michelle Chui will study its effectiveness.
To Die or Not to Die?
School of Pharmacy research reveals new insights into the cell death machinery
Medicinal Chemistry Center Moves Drug Discovery Forward With Unparalleled Expertise
The early phase of drug discovery is seemingly straight-forward: screen molecules for biological activity, validate screening hits, design and synthesize novel drug molecules for testing in cells and animals. But while drug companies breeze through that process